Sacheerome Limited’s Rs 184 crore YEIDA plant awaits certificates

Sacheerome Limited’s approximately Rs 184 crore YEIDA facility was ready for commercial production after trial output began in September 2026, but commercial supplies remained pending on November 4, 2026 because final statutory certificates had not been issued. Management said substantial orders and required raw materials were available for the start.

What is delaying Sacheerome’s YEIDA plant from commercial production?

Sacheerome said final statutory certificates were the remaining disclosed condition before YEIDA could begin commercial production and supplies. On the November 4, 2026 H1 FY27 call, management said installation and commissioning had been completed during the half year, necessary inspections were complete, and trial production had started in September 2026.

The plant was therefore operationally prepared but not yet formally supplying customers on a commercial basis. Management said it had substantial orders and the necessary raw materials to support production once approvals arrive, while Chairman and Managing Director Manoj Arora said the company faced customer pressure to commence supplies as soon as possible.

Sacheerome did not identify the particular certificates outstanding, give an expected approval date, or set a date for initial commercial dispatches. Whole-Time Director Dhruv Arora named receipt of certificates as the first priority, followed by progressively scaling capacity utilisation.

How much has Sacheerome spent on the YEIDA project?

Sacheerome put total YEIDA project capital expenditure at approximately Rs 184 crore and said approximately Rs 110 crore had been incurred by September 30, 2026. Management said the spending was funded by a combination of initial public offering proceeds and internal accruals, and that the initial public offering proceeds had been fully deployed.

Chief Financial Officer Aarti Kashyap said payments remained due to vendors under contractual terms. Management also said the production facility was ready, while some other departments would take more time, and disclosed a Rs 60 crore loan arrangement. It said there was no change to the approximately Rs 184 crore project-capex plan.

The project covers more than plant and machinery. In response to an analyst’s question on the asset mix, management said research and development, quality control and other production-linked functions were necessary for manufacturing and serving customers. It did not provide a numerical allocation between machinery and those functions during the November 4 call.

What will the YEIDA facility add to Sacheerome’s operations?

Sacheerome described YEIDA as a smart green factory combining manufacturing infrastructure with additional capacity and dedicated in-house research and development, quality-control, application and consumer-evaluation centres. The September 2026 trial production was the first disclosed production activity at the facility.

Management said these functions would support formulation development through testing and evaluation. Dhruv Arora said the immediate operational work was to establish consistent processes and use the added infrastructure to meet customer requirements, while preserving formulation quality, production consistency and customer service.

The company said the facility was intended to improve manufacturing capacity and operational efficiency while serving existing and new customers. Its stated priorities included building domestic and international customer relationships, and continuing research, application development and consumer evaluation for fragrance and flavour offerings.

Sacheerome did not disclose annual production capacity, production-line numbers, or an allocation of capacity between fragrances and flavours. The November 4 discussion therefore establishes the facility’s manufacturing and technical role, but does not support a quantified estimate of incremental output or revenue by segment.

How did Sacheerome’s H1 FY27 financial performance compare?

Sacheerome reported total income of Rs 85.92 crore in H1 FY27, up 9.84% from Rs 78.22 crore in H1 FY26. Earnings before interest, taxes, depreciation and amortisation increased 12.27% to Rs 23.69 crore from Rs 21.10 crore, so this profit measure grew faster than income in the reported half year.

Net profit rose 12.38% to Rs 16.79 crore in H1 FY27 from Rs 14.94 crore in the corresponding prior-year period. The company reported an earnings before interest, taxes, depreciation and amortisation margin of 27.57% and a net-profit margin of 19.54% for H1 FY27; management said maintaining efficiency remained a priority during expansion.

Profit growth outpaced total-income growth in H1 FY27. However, YEIDA had only entered trial production in September 2026 and had not begun commercial supplies by the November 4 call, so management did not identify revenue from the new facility within the reported H1 FY27 result.

What has Sacheerome said about revenue and capacity utilisation?

Sacheerome reaffirmed its previously stated combined revenue projection of Rs 300 crore for FY29. When an analyst suggested that the target could appear conservative relative to the Rs 184 crore YEIDA investment and older facilities, Manoj Arora said management stood by the FY29 projection and preferred to provide conservative figures.

Management said its current asset turn was around one, but did not define the calculation or disclose a YEIDA-specific target. It said the added assets could initially affect the ratio as the facility starts, while commercial orders converting into revenue and improved utilisation could improve operating efficiency over time.

No timetable for full utilisation was disclosed on November 4. Dhruv Arora said the ramp-up would be gradual because the facility was just starting, while the company would seek to begin production as soon as possible; the stated sequence was approvals, commercial supplies and progressive utilisation growth.

Conclusion

Sacheerome has completed installation and commissioning of its approximately Rs 184 crore YEIDA project, incurred approximately Rs 110 crore by September 30, 2026 and begun trial production in September 2026. At the same time, H1 FY27 total income rose 9.84% to Rs 85.92 crore and net profit rose 12.38% to Rs 16.79 crore, before commercial supplies from YEIDA began.

The next disclosed milestone is issuance of final statutory certificates, which management identified as necessary for commercial production. After that, the relevant developments are the conversion of available orders and raw materials into supplies, the pace of utilisation ramp-up, and progress toward management’s combined Rs 300 crore FY29 revenue projection.